Tag: 2-DG
Bajaj Healthcare launches Covid drug 2-DG under DGJAJ brand
Bajaj Healthcare Limited (BHL) said that it has launched API and formulation of 2-Deoxy-D-Glucose (2-DG), an antiviral drug used for the treatment of moderate to ... Read More
Dr. Reddy’s Laboratories launches DRDO’s anti-Covid-19 drug 2-DG
Dr. Reddy’s Laboratories has announced the commercial launch of the Defence Research and Development Organisation’s (DRDO) anti-Covid-19 drug 2-deoxy-D-glucose (2-DG). The Indian pharma giant said ... Read More
Suven Pharma partners with CSIR-IICT to manufacture Molnupiravir and 2-DG
Suven Pharmaceuticals (Suven Pharma), CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad and CSIR-National Institute of Interdisciplinary Science & Technology, Thiruvananthapuram have forged an agreement for ... Read More
DCGI gives emergency use approval for DRDO’s anti-COVID drug 2-DG
The Drugs Controller General of India (DCGI) has given emergency use approval for 2-deoxy-D-glucose (2-DG) of Defence Research and Development Organisation (DRDO) for the treatment ... Read More